Search

Author/Creator Nicholson, Simone M.

1. Safety risk management for low molecular weight process‐related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential. (6th January 2021)

Authors:
Luo, Haibin; Li, Yuling; Robbins, David; Wang, Sheau‐Chiann; Xi, Guoling; Cox, Matthew; Nicholson, Simone M.; Wei, Chenghong; Pabst, Timothy M.; Wang, William K.
Journal:
Biotechnology progress
Issue:
Volume 37:Number 3(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys. (3rd February 2020)

Authors:
Nicholson, Simone M.; Casey, Kerry A.; Gunsior, Michele; Drabic, Stacey; Iverson, William; Cook, Halie; Scott, Stephen; O'Day, Terry; Karanth, Subramanya; Dixit, Rakesh; Ryan, Patricia C.
Journal:
British journal of pharmacology
Issue:
Volume 177:Number 5(2020)
Page Start:
1061
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗